SDWIA
CVS icon

Schwarz Dygos Wheeler Investment Advisors’s CVS Health CVS Stock Holding History

Schwarz Dygos Wheeler Investment Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Buy
12,503
+43
+0.3% +$3.84K 0.25% 67
2026
Q1 		$895K Buy
12,460
+632
+5% +$48.7K 0.19% 80
2025
Q4 		$939K Sell
11,828
-38
-0.3% -$3K 0.19% 79
2025
Q3 		$895K Buy
11,866
+305
+3% +$20.9K 0.19% 82
2025
Q2 		$798K Buy
11,561
+1,753
+18% +$115K 0.18% 91
2025
Q1 		$665K Buy
9,808
+100
+1% +$5.98K 0.16% 92
2024
Q4 		$436K Sell
9,708
-10,851
-53% -$609K 0.11% 109
2024
Q3 		$1.29M Sell
20,559
-1,328
-6% -$77.5K 0.32% 56
2024
Q2 		$1.29M Sell
21,887
-544
-2% -$34K 0.35% 57
2024
Q1 		$1.79M Buy
22,431
+582
+3% +$44.5K 0.5% 47
2023
Q4 		$1.73M Buy
21,849
+2,857
+15% +$203K 0.53% 42
2023
Q3 		$1.33M Sell
18,992
-122
-0.6% -$8.64K 0.45% 46
2023
Q2 		$1.32M Buy
19,114
+244
+1% +$17.4K 0.44% 47
2023
Q1 		$1.4M Buy
18,870
+520
+3% +$43.6K 0.51% 44
2022
Q4 		$1.71M Buy
18,350
+38
+0.2% +$3.67K 0.67% 38
2022
Q3 		$1.75M Buy
18,312
+229
+1% +$22.7K 0.77% 37
2022
Q2 		$1.68M Sell
18,083
-541
-3% -$52.8K 0.67% 38
2022
Q1 		$1.89M Sell
18,624
-668
-3% -$70.2K 0.64% 39
2021
Q4 		$1.99M Buy
19,292
+505
+3% +$46.7K 0.67% 39
2021
Q3 		$1.59M Sell
18,787
-5,849
-24% -$490K 0.58% 43
2021
Q2 		$2.06M Buy
24,636
+418
+2% +$34.2K 0.75% 40
2021
Q1 		$1.82M Buy
24,218
+628
+3% +$45.7K 0.75% 38
2020
Q4 		$1.61M Buy
23,590
+3,607
+18% +$235K 0.77% 34
2020
Q3 		$1.17M Sell
19,983
-449
-2% -$27.9K 0.66% 36
2020
Q2 		$1.28M Sell
20,432
-4,571
-18% -$288K 0.83% 33
2020
Q1 		$1.48M Buy
25,003
+5,643
+29% +$377K 1.26% 20
2019
Q4 		$1.44M Buy
19,360
+710
+4% +$49.9K 0.98% 27
2019
Q3 		$1.18M Buy
18,650
+127
+0.7% +$7.53K 0.93% 31
2019
Q2 		$1.01M Buy
18,523
+2,249
+14% +$121K 0.83% 35
2019
Q1 		$878K Sell
16,274
-372
-2% -$23K 0.75% 35
2018
Q4 		$1.09M Buy
+16,646
New +$1.24M 1.18% 25

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Schwarz Dygos Wheeler Investment Advisors's CVS Position: Q2 2026 in Review

Schwarz Dygos Wheeler Investment Advisors increased its CVS Health (CVS) stake by 0.35% in Q2 2026, buying an estimated $3.84K and bringing the position to 12,503 shares worth $1.29M. The position accounts for 0.25% of the portfolio, ranked #67.

Schwarz Dygos Wheeler Investment Advisors first reported a position in CVS in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.06M in Q2 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Schwarz Dygos Wheeler Investment Advisors held 12,503 shares of CVS Health worth $1.29M as of Q2 2026.
  • Schwarz Dygos Wheeler Investment Advisors bought 43 CVS Health shares in Q2 2026, an estimated $3.84K.
  • CVS Health made up 0.25% of Schwarz Dygos Wheeler Investment Advisors's portfolio in Q2 2026, its #67 holding.
  • Schwarz Dygos Wheeler Investment Advisors first reported a position in CVS Health in Q4 2018 and has held it in 31 quarters since.
  • Schwarz Dygos Wheeler Investment Advisors's CVS Health position peaked at $2.06M in Q2 2021.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Schwarz Dygos Wheeler Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.